Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Products
  • 研究・開発
  • タンパク質解析
  • イムノアッセイ
  • HTRF
  • HTRF EPIgeneous Binding Domain C Detection Kit, 500 Assay Points

HTRF EPIgeneous Binding Domain C Detection Kit, 500 Assay Points

Epigeneous binding domain xL665 assay
Video Play Button
HTRF EPIgeneous Binding Domain C Detection Kit, 500 Assay Points
Epigeneous binding domain xL665 assay
Video Play Button
Epigeneous binding domain xL665 assay
Epigeneous binding domain xL665 assay
Epigeneous binding domain xL665 assay
Epigeneous binding domain xL665 assay
Video Play Button

This biochemical assay format enables the detection of the interaction between a subset of epigenetic binding domains and modified histone sequences.

View product information
Feature Specification
Application 生化学酵素アッセイ
Sample Volume 120 µL

This biochemical assay format enables the detection of the interaction between a subset of epigenetic binding domains and modified histone sequences.

View product information
Product variants
Unit Size: 500 assay points
Part #:
62BDCPEG
Unit Size: 10,000 assay points
Part #:
62BDCPEH
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption, and disposal requirements under European REACH regulations (EC 1907/2006).
Request more information
Epigeneous binding domain xL665 assay
Epigeneous binding domain xL665 assay
Video Play Button
HTRF EPIgeneous Binding Domain C Detection Kit, 500 Assay Points
Epigeneous binding domain xL665 assay
Video Play Button
Epigeneous binding domain xL665 assay
Epigeneous binding domain xL665 assay
HTRF EPIgeneous Binding Domain C Detection Kit, 500 Assay Points
Epigeneous binding domain xL665 assay
Epigeneous binding domain xL665 assay
Video Play Button
Quick links
  • Variants
  • Video
  • Product information
  • Resources
  • SDS, COAs, manuals and more
  • Related products
  • Recently viewed
  • Customers also bought
  • Get help

Product information

  • Overview
  • How it works
  • Analytical performance
  • Assay validation
  • Specifications
  • Video gallery

Overview

The EPIgeneous Binding Domain kit series provides a simple biochemical approach to study epigenetic reader domain interactions with modified histones. All kits are based on a GST-tagged binding domain / biotin-coupled Histone peptide format, and can be run using the same add-and-read single plate protocol.

Binding Domain kit C has been successfully validated on 4 different domains, including some important therapeutic targets, in the BRD and ATAD families.

How it works

Assay principle

In EPIgeneous Binding Domain kit B, the GST-tagged reader domain protein binding to the biotinylated peptide substrate is detected by a conjugate mix: anti-GST Tb cryptate-labeled antibody conjugate (donor), and XL665-conjugated streptavidin (acceptor). The interaction of the reader domain with the substrate brings the donor and acceptor dyes into close proximity, and allows FRET to occur upon light excitation. The specific signal at 665 nm is inhibited when a specific compound prevents the reader domain protein from binding to its substrate.

The referenced media source is missing and needs to be re-embedded.

 

Analytical performance

Peptide-biotin titration - ATAD2 / histone H4 peptide interaction

The validation of the EPIgeneous binding Domain C assay was performed using Bromodomain ATAD2A assay which measures the interaction of ATAD2A with [Lys(5,8,12,16)Ac] H4(1-21) peptide. The GST-ATAD2A concentration was fixed at 5 nM while the peptide-biotin was serially diluted.

The HTRF signal is proportional to the specific interaction between the two partners.

The 400 nM Kd value was determined using a two-site specific binding regression. A slight shift of apparent Kd is observed while DMSO% increases, likely due to the competitive inhibitor nature of DMSO on this interaction.

analytical-performance-binding-domain-kit-c-1
DMSO tolerance - peptide-biotin concentration optimization

Due to the competitive nature of DMSO, the assay window decreased as the DMSO % increased. The assay window can then be recovered by increasing the biotinylated peptide concentration. The best compromise was found between the real Kd and EC100 obtained in DMSO free conditions.

Note that the the higher the biotin-peptide concentration, the higher the inhibitor IC50. 1% DMSO and 300 nM were considered for further experiments.

analytical-performance-binding-domain-kit-c-2
Inhibitor titration - ATAD2A by reference compound

The HTRF assay was performed using 100 nM peptide-biotin, 5 nM GST-ATAD2A and 1% DMSO set constant throughout the inhibitor titration. As expected, the [Lys(5,8,12,16)Ac] H4(1-25) peptide displayed low affinity for ATAD2A.

analytical-performance-binding-domain-kit-c-3

 

Assay validation

Validated binding domains

Three kits (A, B and C) have already been validated and fully optimized on a selection of 28 key binding domains. For non-validated reader domains, a fourth one, the Discovery Kit, enables researchers to profile which of the A, B or C kits is the best assay solution.

 

The referenced media source is missing and needs to be re-embedded.

 

BINDING DOMAIN KIT A BINDING DOMAIN KIT B BINDING DOMAIN KIT C
BRD2(1) CECR2 BRD4(1/2)
BRD3(1) FALZ (BPTF) ATAD2A
BRD4(1) BRD2(2) ATAD2B
CBX 1 BRD2(1/2) BRD9
  BRD3(2) SMARCA4 (BRG1)
  BRD3(1/2) BAZ2B
  BRD4(2)  
  BRDT(1)  
  BRDT(1/2)  
  CREBBP  
  BRD1  
  BRPF3  
  TAF1L(2)  
  TAF1L(1/2)  
  TAF1(2)  
  TAF1(1/2)  
  L3MBTL1  
  UHRF1  

 

 

Specifications

Application
Biochemical Enzymatic Assay
Brand
EPIgeneous
Detection Modality
HTRF
Product Group
Kit
Sample Volume
120 µL
Shipping Conditions
Shipped in Dry Ice
Target Class
Epigenetics
Technology
TR-FRET
Therapeutic Area
Metabolism/Diabetes
Neuroscience
Oncology & Inflammation
Unit Size
500 assay points

Video gallery

HTRF EPIgeneous Binding Domain C Detection Kit, 500 Assay Points
HTRF EPIgeneous Binding Domain C Detection Kit, 500 Assay Points

Resources

Are you looking for resources, click on the resource type to explore further.

  • - すべて -:-:- Any -
  • Brochure:-:1
  • Guide:-:1
1-2 of 2 Resources
Brochure Icon
Brochure
HTRF assays and reagents product list

Discover the versatility and precision of Homogeneous Time-Resolved Fluorescence (HTRF) technology. Our HTRF portfolio offers a...

Learn more
Guide Icon
Guide
HTRF solutions, guide to major applications

This guide provides you an overview of HTRF applications in several therapeutic areas.

Learn more

How can we help you?

We are here to answer your questions.

Contact sales I would like more product information Contact customer care Get technical support
Get Help Illustration Get Help Illustration
Scroll Icon
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.